Clorox (CLX) Tops Q4 EPS by 51c

Clorox (NYSE: CLX) reported Q4 EPS of $1.67, $0.51 better than the analyst estimate of $1.16. Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.88 billion.

GUIDANCE:

Clorox sees FY2024 EPS of $5.60-$5.90, versus the consensus of $5.63. Net sales are expected to be flat to up 2% compared to the prior year. Organic sales are expected to be up 2% to up 4%

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c